Literature DB >> 24573039

[Neoadjuvant short-course radiotherapy followed by chemotherapy or simultaneous radiochemotherapy for local unresectable rectal cancer].

G Klautke1, R Sauer.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24573039     DOI： 10.1007/s00066-013-0549-1

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  5 in total

1.  Initial results of a randomized controlled trial comparing clinical and pathological downstaging of rectal cancer after preoperative short-course radiotherapy or long-term chemoradiotherapy, both with delayed surgery.

Authors:  T Latkauskas; H Pauzas; I Gineikiene; R Janciauskiene; E Juozaityte; Z Saladzinskas; A Tamelis; D Pavalkis
Journal:  Colorectal Dis       Date:  2012-03       Impact factor: 3.788

2.  Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.

Authors:  Claus Rödel; Torsten Liersch; Heinz Becker; Rainer Fietkau; Werner Hohenberger; Torsten Hothorn; Ullrich Graeven; Dirk Arnold; Marga Lang-Welzenbach; Hans-Rudolf Raab; Heiko Sülberg; Christian Wittekind; Sergej Potapov; Ludger Staib; Clemens Hess; Karin Weigang-Köhler; Gerhard G Grabenbauer; Hans Hoffmanns; Fritz Lindemann; Anke Schlenska-Lange; Gunnar Folprecht; Rolf Sauer
Journal:  Lancet Oncol       Date:  2012-05-23       Impact factor: 41.316

3.  Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: results of study CAO/ARO/AIO-94.

Authors:  Rainer Fietkau; Claus Rödel; Werner Hohenberger; Rudolf Raab; Clemens Hess; Torsten Liersch; Heinz Becker; Christian Wittekind; Matthias Hutter; Eva Hager; Johann Karstens; Hermann Ewald; Norbert Christen; Michael Jagoditsch; Peter Martus; Rolf Sauer
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-29       Impact factor: 7.038

4.  Neoadjuvant treatment for unresectable rectal cancer: an interim analysis of a multicentre randomized study.

Authors:  Krzysztof Bujko; Anna Nasierowska-Guttmejer; Lucjan Wyrwicz; Małgorzata Malinowska; Jacek Krynski; Ewa Kosakowska; Andrzej Rutkowski; Lucyna Pietrzak; Lucyna Kepka; Jakub Radziszewski; Marta Olszyna-Serementa; Magdalena Bujko; Anna Danek; Mariusz Kryj; Jerzy Wydmanski; Wojciech Zegarski; Wlodzimierz Markiewicz; Tadeusz Lesniak; Ireneusz Zygulski; Dorota Porzuczek-Zuziak; Marek Bebenek; Adam Maciejczyk; Wojciech Polkowski; Beata Czeremszynska; Ewa Cieslak-Zeranska; Zygmunt Toczko; Andrzej Radkowski; Leszek Kolodziejski; Marek Szczepkowski; Adam Majewski; Michal Jankowski
Journal:  Radiother Oncol       Date:  2013-04-13       Impact factor: 6.280

5.  Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04.

Authors:  Samuel Y Ngan; Bryan Burmeister; Richard J Fisher; Michael Solomon; David Goldstein; David Joseph; Stephen P Ackland; David Schache; Bev McClure; Sue-Anne McLachlan; Joseph McKendrick; Trevor Leong; Cris Hartopeanu; John Zalcberg; John Mackay
Journal:  J Clin Oncol       Date:  2012-09-24       Impact factor: 44.544
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.